Cellectis SA (CLLS)
1.76
-0.04
(-2.22%)
USD |
NASDAQ |
Nov 04, 16:00
1.77
+0.01
(+0.57%)
After-Hours: 20:00
Cellectis Total Assets (Quarterly): 407.15M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 407.15M |
| March 31, 2024 | 354.46M |
| December 31, 2023 | 334.27M |
| September 30, 2023 | 209.70M |
| June 30, 2023 | 227.67M |
| March 31, 2023 | 251.41M |
| December 31, 2022 | 261.22M |
| September 30, 2022 | 279.58M |
| June 30, 2022 | 320.88M |
| March 31, 2022 | 347.19M |
| December 31, 2021 | 382.08M |
| September 30, 2021 | 412.89M |
| June 30, 2021 | 457.56M |
| March 31, 2021 | 442.71M |
| December 31, 2020 | 469.47M |
| September 30, 2020 | 484.96M |
| June 30, 2020 | 472.70M |
| March 31, 2020 | 471.14M |
| December 31, 2019 | 467.47M |
| September 30, 2019 | 480.48M |
| June 30, 2019 | 505.32M |
| March 31, 2019 | 511.94M |
| December 31, 2018 | 500.84M |
| September 30, 2018 | 519.80M |
| June 30, 2018 | 534.07M |
| Date | Value |
|---|---|
| March 31, 2018 | 324.05M |
| December 31, 2017 | 332.88M |
| September 30, 2017 | 349.40M |
| June 30, 2017 | 328.64M |
| March 31, 2017 | 325.85M |
| December 31, 2016 | 331.43M |
| September 30, 2016 | 352.47M |
| June 30, 2016 | 358.60M |
| March 31, 2016 | 356.59M |
| December 31, 2015 | 372.88M |
| September 30, 2015 | 339.96M |
| June 30, 2015 | 344.65M |
| March 31, 2015 | 367.94M |
| December 31, 2014 | 167.34M |
| June 30, 2014 | 58.59M |
| December 31, 2013 | 39.87M |
| June 30, 2013 | 90.93M |
| June 30, 2013 | 90.93M |
| December 31, 2012 | 102.45M |
| June 30, 2012 | 117.35M |
| June 30, 2012 | 117.35M |
| December 31, 2011 | 131.89M |
| December 31, 2010 | 68.81M |
| June 30, 2010 | 72.34M |
| June 30, 2010 | 72.34M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
209.70M
Minimum
Sep 2023
484.96M
Maximum
Sep 2020
371.29M
Average
382.08M
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Genfit SA | 192.20M |
| DBV Technologies SA | 114.19M |
| Edap TMS SA | 88.07M |
| Adaptimmune Therapeutics PLC | 321.70M |
| Akari Therapeutics PLC | 5.076M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 258.54M |
| Shareholders Equity (Quarterly) | 148.61M |
| Debt to Equity Ratio | 0.2995 |
| Current Ratio | 1.915 |
| Net Debt Paydown Yield | -2.87% |